<bill session="118" type="s" number="1182" updated="2025-04-21T12:24:17Z">
  <state datetime="2023-04-18">REFERRED</state>
  <status>
    <introduced datetime="2023-04-18"/>
  </status>
  <introduced datetime="2023-04-18"/>
  <titles>
    <title type="display">340B Reporting and Accountability Act</title>
    <title type="short" as="introduced">340B Reporting and Accountability Act</title>
    <title type="official" as="introduced">A bill to amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="K000393"/>
  <cosponsors/>
  <actions>
    <action datetime="2023-04-18">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-04-18" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2024-03-28T19:15:23Z" status="Introduced in Senate">340B Reporting and Accountability Act

This bill requires providers participating in the 340B drug discount program to ensure patients receive covered outpatient drugs at a price that does not exceed the amount the provider paid, minus any additional discounts or rebates the provider receives.

Further, participating providers must report annually information about amounts paid and received for covered outpatient drugs and how any excess revenue was spent.</summary>
</bill>
